Triple-negative BC (TNBC) is defined by the absence of ER, PR, and HER2 expression, and is characterized by a more aggressive clinical course, poorer prognosis, and higher rates of metastasis and recurrence compared with other BC subtypes [3]. The gene discussed is ESR1; the disease is breast cancer.